Moreover, obesity-related neuroinflammation has been shown to impair serotonin transporter (SERT) expression in the hippocampus, potentially elucidating the diminished responsiveness to SSRIs observed in obese individuals with comorbid depression (54). Here, SLC6A4 is linked to obesity due to melanocortin 4 receptor deficiency.